OBJECTIVEdInformation on diabetes prevalence in the general population is scarce and often based on extrapolations.We evaluatedwhether prevalence could be estimated from routine data sources. RESEARCHDESIGNANDMETHODSdThe sources were 1) hospital discharges (2008, n = 828,171), 2) death registry (2007/2008, n = 118,659), and 3) Swiss Health Survey (SHS; 2007, n = 18,665). Persons without diabetes as underlying cause of death (death registry) or principal diagnosis (hospital discharges) were regarded as surrogate for a general population random sample. RESULTSdIn those aged 20–84 years, 4.5 % of men and 3 % of women were expected to have diabetes. By source, estimations were 4.4 and 2.8 % (hospital discharges), 3.8 and 3.1 % (death registry),...
Background: One of the global targets for non-communicable diseases is to halt, by 2025, the rise in...
BACKGROUND: One of the global targets for non-communicable diseases is to halt, by 2025, the rise in...
BackgroundOne of the global targets for non-communicable diseases is to halt, by 2025, the rise in t...
We note with interest the approach ofBopp et al. (1) in providing conser-vative estimates for the pr...
Objective: Concerning diabetes mellitus, one of the greatest burdens in public health in the 21st ce...
BACKGROUND: Prevalence estimates of chronic medical conditions and their multiples (multimorbidity) ...
Introduction To estimate the prevalence of and trends in diabetes according to sociodemographic indi...
Background: Recent decades have seen a constant upward projection in the prevalence of diabetes. Att...
BACKGROUND: The database of the German Institute of Medical Documentation and Information makes it p...
Aim:  In Germany, regional data on the prevalence of Type 2 diabetes mellitus are lacking for h...
Background Quantifying the burden of diabetes mellitus is fundamental for managing patients in healt...
BACKGROUND: There is little information regarding the prevalence and management of dyslipidaemia in ...
© NCD Risk Factor Collaboration.Background: One of the global targets for non-communicable diseases ...
Aims:The few studies examining the secular trend in diabetes prevalence in Germany have yielded conf...
Background - One of the global targets for non-communicable diseases is to halt, by 2025, the rise i...
Background: One of the global targets for non-communicable diseases is to halt, by 2025, the rise in...
BACKGROUND: One of the global targets for non-communicable diseases is to halt, by 2025, the rise in...
BackgroundOne of the global targets for non-communicable diseases is to halt, by 2025, the rise in t...
We note with interest the approach ofBopp et al. (1) in providing conser-vative estimates for the pr...
Objective: Concerning diabetes mellitus, one of the greatest burdens in public health in the 21st ce...
BACKGROUND: Prevalence estimates of chronic medical conditions and their multiples (multimorbidity) ...
Introduction To estimate the prevalence of and trends in diabetes according to sociodemographic indi...
Background: Recent decades have seen a constant upward projection in the prevalence of diabetes. Att...
BACKGROUND: The database of the German Institute of Medical Documentation and Information makes it p...
Aim:  In Germany, regional data on the prevalence of Type 2 diabetes mellitus are lacking for h...
Background Quantifying the burden of diabetes mellitus is fundamental for managing patients in healt...
BACKGROUND: There is little information regarding the prevalence and management of dyslipidaemia in ...
© NCD Risk Factor Collaboration.Background: One of the global targets for non-communicable diseases ...
Aims:The few studies examining the secular trend in diabetes prevalence in Germany have yielded conf...
Background - One of the global targets for non-communicable diseases is to halt, by 2025, the rise i...
Background: One of the global targets for non-communicable diseases is to halt, by 2025, the rise in...
BACKGROUND: One of the global targets for non-communicable diseases is to halt, by 2025, the rise in...
BackgroundOne of the global targets for non-communicable diseases is to halt, by 2025, the rise in t...